Literature DB >> 2566853

Ifosfamide-induced Fanconi syndrome.

R A Newbury-Ecob, V W Noble, P R Barbor.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2566853     DOI: 10.1016/s0140-6736(89)92719-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

Review 1.  Ifosfamide/mesna. A review of its antineoplastic activity, pharmacokinetic properties and therapeutic efficacy in cancer.

Authors:  K L Dechant; R N Brogden; T Pilkington; D Faulds
Journal:  Drugs       Date:  1991-09       Impact factor: 9.546

2.  Hypophosphatemic rickets after ifosfamide treatment.

Authors:  R A Newbury-Ecob; P R Barbor
Journal:  BMJ       Date:  1989-07-22

3.  Nephrotoxicity after ifosfamide.

Authors:  R Skinner; A D Pearson; L Price; M G Coulthard; A W Craft
Journal:  Arch Dis Child       Date:  1990-07       Impact factor: 3.791

4.  Urinary excretion of the enantiomers of ifosfamide and its inactive metabolites in children.

Authors:  J Boos; U Welslau; J Ritter; G Blaschke; G Schellong
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

Review 5.  Dosing and side-effects of ifosfamide plus mesna.

Authors:  W P Brade; K Herdrich; U Kachel-Fischer; C E Araujo
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

6.  Tubular function and histological findings in ifosfamide-induced renal Fanconi syndrome--a report of two cases.

Authors:  R Rossi; U Helmchen; G Schellong
Journal:  Eur J Pediatr       Date:  1992-05       Impact factor: 3.183

7.  The influence of age on nephrotoxicity following chemotherapy in children.

Authors:  R Skinner; A D Pearson; L Price; M G Coulthard; A W Craft
Journal:  Br J Cancer Suppl       Date:  1992-08

Review 8.  Anticancer drug-induced kidney disorders.

Authors:  P E Kintzel
Journal:  Drug Saf       Date:  2001-01       Impact factor: 5.228

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.